Published in J Clin Microbiol on January 01, 1997
Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 3.19
Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 2.61
Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect Dis (2004) 2.17
Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol (2004) 1.64
Clinical evaluation of the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid diagnosis of tuberculosis in prison inmates. J Clin Microbiol (1999) 1.61
Evaluation of Gen-Probe amplified mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory. J Clin Microbiol (2002) 1.56
Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis. J Clin Microbiol (1999) 1.53
Rapid diagnosis of extrapulmonary tuberculosis by ligase chain reaction amplification. J Clin Microbiol (1998) 1.22
Clinical evaluation of the BDProbeTec strand displacement amplification assay for rapid diagnosis of tuberculosis. J Clin Microbiol (1998) 1.12
Evaluation of the BDProbeTec ET system for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples: a multicenter study. J Clin Microbiol (2003) 1.12
Multicenter evaluation of the Abbott LCx Mycobacterium tuberculosis ligase chain reaction assay. J Clin Microbiol (1999) 1.10
Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNA. J Clin Microbiol (1999) 0.95
Detection and identification of mycobacteria by amplification of RNA and DNA in pretreated blood and bone marrow aspirates by a simple lysis method. J Clin Microbiol (1997) 0.92
Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J Clin Microbiol (1990) 9.53
Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol (1993) 6.65
Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. J Clin Microbiol (1988) 6.42
Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J Clin Microbiol (1993) 6.38
Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet (1991) 6.37
Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis. J Clin Microbiol (1991) 5.99
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84
A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol (1994) 5.43
Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria. J Clin Microbiol (1992) 4.55
Direct detection of Mycobacterium tuberculosis in respiratory specimens in a clinical laboratory by polymerase chain reaction. J Clin Microbiol (1993) 4.52
Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1993) 4.04
Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens. J Clin Microbiol (1996) 3.85
Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by a target-amplified test system. J Clin Microbiol (1994) 3.81
Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and PCR for direct detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol (1994) 3.74
Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures. J Clin Microbiol (1994) 3.11
Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria. J Clin Microbiol (1991) 3.00
Screening of respiratory tract specimens for the presence of Mycobacterium tuberculosis by using the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1994) 2.94
Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium-ester-labeled DNA probes. J Clin Microbiol (1992) 2.86
Diagnostic value of an amplification method (Gen-Probe) compared with that of culture for diagnosis of tuberculosis. J Clin Microbiol (1995) 2.14
The rapid diagnosis of tuberculosis: a selective review. J Lab Clin Med (1990) 1.97
Diagnosis of extrapulmonary tuberculosis by Gen-Probe amplified Mycobacterium tuberculosis direct test. J Clin Microbiol (1996) 1.58
Improved performance of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test when 500 instead of 50 microliters of decontaminated sediment is used. J Clin Microbiol (1996) 1.52
Assessment of mycobacterial viability by RNA amplification. Antimicrob Agents Chemother (1994) 1.51
Evaluation of a commercial rRNA target amplification assay for detection of Mycobacterium tuberculosis complex in respiratory specimens. Eur J Clin Microbiol Infect Dis (1994) 1.28
Evaluation of a commercial rRNA amplification assay for direct detection of Mycobacterium tuberculosis in processed sputum. Eur J Clin Microbiol Infect Dis (1994) 1.27
[Media and methods of culture suitable for the reanimation and multiplication in vitro of Mycobacterium tuberculosis of reduced vitality, of ephemeral viability, or in a state of quiescence]. Ann Inst Pasteur (Paris) (1960) 1.11
Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest (2001) 3.28
Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 3.19
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J (2009) 3.16
[Helicobacter pylori: an etiologic factor in chronic gastritis, gastroduodenal ulcer and gastric cancer]. Med Clin (Barc) (1995) 3.09
Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria. J Clin Microbiol (1991) 3.00
How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Respir Crit Care Med (2000) 2.87
Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. Chest (1999) 2.81
[Current status of tuberculosis in Spain. A precarious health care perspective with regard to developed countries]. Med Clin (Barc) (1995) 2.58
Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest (1993) 2.56
Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med (1999) 2.40
Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and posttreatment check-up. Am J Gastroenterol (2000) 2.32
Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest (1998) 2.16
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 2.08
[Prognosis for acute exacerbation of chronic obstructive pulmonary disease in mechanically ventilated patients]. Med Intensiva (2006) 1.97
Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med (1998) 1.93
Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J (1999) 1.93
Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis (1999) 1.88
The professional public health worker: educational and demographic profiles. Am J Public Health (1975) 1.80
GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol (2008) 1.71
Physiology and ultrastructure of electrotonic junctions. IV. Medullary electromotor nuclei in gymnotid fish. J Neurophysiol (1967) 1.68
Evaluation of a new serodiagnostic tuberculosis test based on immunoglobulin A detection against Kp-90 antigen. Int J Tuberc Lung Dis (2000) 1.64
[Proteinuria and chronic renal failure in the coast of El Salvador: detection with low cost methods and associated factors]. Nefrologia (2005) 1.59
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. Eur Respir J (2010) 1.58
Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol (1998) 1.57
Evaluation of the semiautomated Abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol (1997) 1.51
Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine samples. Eur J Clin Microbiol Infect Dis (1999) 1.50
[Drug resistance in Mycobacterium tuberculosis. A multicenter study of the Barcelona area. Grupo de Trabajo sobre Resistencias en Tuberculosis]. Med Clin (Barc) (2000) 1.48
Early prediction of poor response in acute asthma patients in the emergency department. Chest (1998) 1.48
Human infection with Hymenolepis diminuta: case report from Spain. J Clin Microbiol (1998) 1.48
[Impact of control measures on the course of an outbreak of methicillin-resistant Staphylococcus aureus]. Med Clin (Barc) (1997) 1.46
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis (1995) 1.46
Treatment of hemobilia with selective hepatic artery embolization. J Vasc Interv Radiol (1996) 1.45
Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J Clin Microbiol (1996) 1.44
[Protected bronchoalveolar lavage: a new endoscopic method in the diagnosis of bacterial pneumonia]. Med Clin (Barc) (1991) 1.40
[Factors associated with pleural thickening in pleural tuberculosis. Review of 99 cases]. An Med Interna (1996) 1.39
[Complications in Mediterranean boutonneuse fever: prospective study of 78 patients]. Rev Clin Esp (1989) 1.39
Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis (1998) 1.39
[Detection of bacteremia in patients discharged from an emergency unit: study of 61 cases]. Med Clin (Barc) (1998) 1.38
Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH. Eur J Clin Microbiol Infect Dis (2004) 1.33
Analysis of cellular immune response in pigs recovered from porcine respiratory and reproductive syndrome infection. Virus Res (1999) 1.32
The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol (1999) 1.30
Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol (2003) 1.26
The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation. J Immunol (1999) 1.25
Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother (1996) 1.24
Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development. Int J Dev Biol (1994) 1.22
Rapid diagnosis of extrapulmonary tuberculosis by ligase chain reaction amplification. J Clin Microbiol (1998) 1.22
Embolization of bronchial arteries of anomalous origin. Cardiovasc Intervent Radiol (1998) 1.22
Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur J Clin Microbiol Infect Dis (2010) 1.21
Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest (1991) 1.21
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Majorcan hospitals: high prevalence of the epidemic clone EMRSA-15. Clin Microbiol Infect (2007) 1.21
Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand J Immunol (2000) 1.20
Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol (1998) 1.19
Evaluation of a fluorescence hybridisation assay using peptide nucleic acid probes for identification and differentiation of tuberculous and non-tuberculous mycobacteria in liquid cultures. Eur J Clin Microbiol Infect Dis (2000) 1.17
Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol (2003) 1.16